Aurora Spine received Institutional Review Board approval for a multicenter study of its Dexa-C cervical interbody system.
Seven sites were approved, and three more are pending, according to an April 4 company news release. The initial study will look at 40 single-level patients and 40 multilevel patients.
The Dexa-C system is approved for anterior cervical interbody fusion and uses the company’s technology for measuring bone density. Sebastian Koga, MD, will be the principal investigator for the study.
The FDA has cleared Spineart’s Perla TL application for use with eCential Robotics Op.nTM robotic navigation platform. The clearance will…
Here are six key updates from spine and orthopedic companies since March 5. 1. Aurora Spine completed enrollment for its…
Medtech company Globus Medical has expanded its spine portfolio by launching its Cohere anterior lumbar interbody fusion spacer and Modulus…